Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yuya Muramoto

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 22, 2023
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.

Takeharu Nakamura, Yoshihiro Nishikawa, Masahiro Shiokawa

Pageof 1

Frequent Collaborators

1 joint publications

Takeharu Nakamura

1 joint publications

Yoshihiro Nishikawa

1 joint publications

Haruhiko Takeda

1 joint publications

Norimitsu Uza

1 joint publications

Etsuro Hatano

1 joint publications

Hiroshi Seno

Frequent Collaborators

1 joint publications

Takeharu Nakamura

1 joint publications

Yoshihiro Nishikawa

1 joint publications

Haruhiko Takeda

1 joint publications

Norimitsu Uza

Top Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on : Oct 27, 2020

13.1K
See more related videos

Top Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on : Oct 27, 2020

13.1K
See more related videos